EirGenix (6589) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.020x

Based on the latest financial reports, EirGenix (6589) has a cash flow conversion efficiency ratio of -0.020x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-168.94 Million ≈ $-5.32 Million USD) by net assets (NT$8.46 Billion ≈ $266.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

EirGenix - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how EirGenix's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read EirGenix debt and liabilities for a breakdown of total debt and financial obligations.

EirGenix Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of EirGenix ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Girisim Elektrik Taahhut Ticaret & Sanayi AS IS:GESAN	0.006x
Changchun Zhiyuan New Energy Equipment Co. Ltd SHE:300985	0.112x
Sarkuysan Elektrolitik Bakir Sanayi ve Ticaret AS IS:SARKY	-0.017x
iQIYI Inc F:IQ8	-0.020x
APG SGA SA SW:APGN	0.000x
ECN Capital Corp TO:ECN	-0.057x
Zhewen Pictures Group Co Ltd SHG:601599	0.048x
Stingray Group Inc TO:RAY-A	0.116x

Annual Cash Flow Conversion Efficiency for EirGenix (2017–2024)

The table below shows the annual cash flow conversion efficiency of EirGenix from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of EirGenix.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$9.26 Billion ≈ $291.69 Million	NT$-311.44 Million ≈ $-9.81 Million	-0.034x	+60.29%
2023-12-31	NT$10.02 Billion ≈ $315.61 Million	NT$-848.56 Million ≈ $-26.73 Million	-0.085x	-513.43%
2022-12-31	NT$10.68 Billion ≈ $336.57 Million	NT$-147.52 Million ≈ $-4.65 Million	-0.014x	-381.65%
2021-12-31	NT$10.43 Billion ≈ $328.56 Million	NT$-29.90 Million ≈ $-941.98K	-0.003x	+98.70%
2020-12-31	NT$1.91 Billion ≈ $60.04 Million	NT$-419.26 Million ≈ $-13.21 Million	-0.220x	+7.36%
2019-12-31	NT$3.30 Billion ≈ $104.01 Million	NT$-784.07 Million ≈ $-24.70 Million	-0.237x	-6.49%
2018-12-31	NT$2.09 Billion ≈ $65.77 Million	NT$-465.61 Million ≈ $-14.67 Million	-0.223x	-34.68%
2017-12-31	NT$1.14 Billion ≈ $36.07 Million	NT$-189.57 Million ≈ $-5.97 Million	-0.166x	--

About EirGenix

TWO:6589 Taiwan Biotechnology

Market Cap

$632.48 Million

NT$20.08 Billion TWD

Market Cap Rank

#11429 Global

#394 in Taiwan

Share Price

NT$66.40

Change (1 day)

+0.45%

52-Week Range

NT$59.60 - NT$66.40

All Time High

NT$188.50